Literature DB >> 15232605

A noninflammatory pathway for pregnancy loss: innate immune activation?

Jane E Salmon1.   

Abstract

Although the mechanisms of immune-mediated pregnancy loss are unknown, investigations are currently focused on mediators of immune activation and tissue injury at the maternal-fetal interface. A new study, however, demonstrates that systemic inflammatory mediators can induce pregnancy failure in a different way, by inhibiting ovarian hormone production, and identifies links between the immune and reproductive endocrine systems.

Entities:  

Mesh:

Year:  2004        PMID: 15232605      PMCID: PMC437974          DOI: 10.1172/JCI22258

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

Review 1.  At the innate frontiers between mother and fetus: linking abortion with complement activation.

Authors:  Stéphane M Caucheteux; Colette Kanellopoulos-Langevin; David M Ojcius
Journal:  Immunity       Date:  2003-02       Impact factor: 31.745

Review 2.  Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppression.

Authors:  A L Mellor; D H Munn
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

3.  Regulation by C5a of neutrophil activation during sepsis.

Authors:  Niels C Riedemann; Ren-Feng Guo; Kurt D Bernacki; Jayne S Reuben; Ines J Laudes; Thomas A Neff; Hongwei Gao; Cecilia Speyer; Vidya J Sarma; Firas S Zetoune; Peter A Ward
Journal:  Immunity       Date:  2003-08       Impact factor: 31.745

4.  Cytokine promoter gene polymorphisms and idiopathic recurrent pregnancy loss.

Authors:  S J Babbage; P D Arkwright; G S Vince; C Perrey; V Pravica; S Quenby; M Bates; I V Hutchinson
Journal:  J Reprod Immunol       Date:  2001-07       Impact factor: 4.054

5.  Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy.

Authors:  A L Mellor; J Sivakumar; P Chandler; K Smith; H Molina; D Mao; D H Munn
Journal:  Nat Immunol       Date:  2001-01       Impact factor: 25.606

6.  Complement and dilated cardiomyopathy: a role of sublytic terminal complement complex-induced tumor necrosis factor-alpha synthesis in cardiac myocytes.

Authors:  Thomas P Zwaka; Dimitar Manolov; Cüneyt Ozdemir; Nikolaus Marx; Ziya Kaya; Matthias Kochs; Martin Höher; Vinzenz Hombach; Jan Torzewski
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

7.  Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome.

Authors:  Guillermina Girardi; Jessica Berman; Patricia Redecha; Lynn Spruce; Joshua M Thurman; Damian Kraus; Travis J Hollmann; Paolo Casali; Michael C Caroll; Rick A Wetsel; John D Lambris; V Michael Holers; Jane E Salmon
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

Review 8.  Cytokines and steroidogenesis.

Authors:  S R Bornstein; H Rutkowski; I Vrezas
Journal:  Mol Cell Endocrinol       Date:  2004-02-27       Impact factor: 4.102

9.  Regulatory T cells mediate maternal tolerance to the fetus.

Authors:  Varuna R Aluvihare; Marinos Kallikourdis; Alexander G Betz
Journal:  Nat Immunol       Date:  2004-02-01       Impact factor: 25.606

10.  Complement C3 activation is required for antiphospholipid antibody-induced fetal loss.

Authors:  V Michael Holers; Guillermina Girardi; Lian Mo; Joel M Guthridge; Hector Molina; Silvia S Pierangeli; Ricardo Espinola; Liu E Xiaowei; Dailing Mao; Christopher G Vialpando; Jane E Salmon
Journal:  J Exp Med       Date:  2002-01-21       Impact factor: 14.307

View more
  3 in total

Review 1.  Immunotherapy for recurrent miscarriage.

Authors:  Luchin F Wong; T Flint Porter; James R Scott
Journal:  Cochrane Database Syst Rev       Date:  2014-10-21

2.  Immunopharmacology of ulipristal as an emergency contraceptive.

Authors:  Ralph P Miech
Journal:  Int J Womens Health       Date:  2011-11-22

3.  Risk of miscarriage among users of corticosteroid hormones: a population-based nested case-control study.

Authors:  Anne-Mette B Bjørn; Rikke B Nielsen; Mette Nørgaard; Ellen A Nohr; Vera Ehrenstein
Journal:  Clin Epidemiol       Date:  2013-08-14       Impact factor: 4.790

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.